IRIS
MOAVERO, ROMINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.754
AS - Asia 2.595
EU - Europa 1.611
SA - Sud America 421
AF - Africa 39
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 6
Totale 23.447
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.696
SG - Singapore 1.552
BR - Brasile 346
IT - Italia 331
CN - Cina 287
HK - Hong Kong 286
IE - Irlanda 240
DE - Germania 223
UA - Ucraina 222
RU - Federazione Russa 138
KR - Corea 130
GB - Regno Unito 123
VN - Vietnam 111
FR - Francia 80
FI - Finlandia 72
NL - Olanda 52
PL - Polonia 44
TW - Taiwan 44
AR - Argentina 37
IN - India 36
JP - Giappone 32
CA - Canada 27
MX - Messico 24
SE - Svezia 23
AT - Austria 22
AU - Australia 21
ID - Indonesia 20
BD - Bangladesh 16
IQ - Iraq 16
ZA - Sudafrica 14
EC - Ecuador 12
TR - Turchia 12
CZ - Repubblica Ceca 8
ES - Italia 8
SA - Arabia Saudita 7
UZ - Uzbekistan 7
VE - Venezuela 7
PK - Pakistan 6
CO - Colombia 5
EG - Egitto 5
EU - Europa 5
MA - Marocco 5
MY - Malesia 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
KE - Kenya 4
PE - Perù 4
PY - Paraguay 4
KZ - Kazakistan 3
UY - Uruguay 3
BE - Belgio 2
BH - Bahrain 2
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
SM - San Marino 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GR - Grecia 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TH - Thailandia 1
Totale 23.447
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.442
Wilmington 4.708
Houston 3.811
Fairfield 743
Singapore 702
Ann Arbor 413
Ashburn 349
Chandler 316
Seattle 305
Hong Kong 282
Cambridge 232
Dublin 229
Jacksonville 186
Medford 178
Beijing 142
Santa Clara 126
Rome 112
Los Angeles 98
Dearborn 97
New York 89
Lawrence 88
Dallas 76
Buffalo 68
Chicago 59
The Dalles 58
Council Bluffs 42
Taipei 42
Ho Chi Minh City 36
Menlo Park 36
Norwalk 35
San Diego 34
Hanoi 33
Kraków 33
São Paulo 30
Munich 29
London 24
Salt Lake City 23
Milan 22
Nuremberg 22
Redondo Beach 20
Moscow 19
Lappeenranta 18
Jakarta 17
Mülheim 16
Del Norte 14
Redwood City 14
Tokyo 14
Rio de Janeiro 13
Elk Grove Village 12
Melbourne 12
Phoenix 12
Warsaw 11
Lancaster 10
Seoul 10
Stockholm 10
Vienna 10
Villa Adelina 10
Boardman 9
Chennai 9
Denver 9
Mexico City 9
Catania 8
Curitiba 8
Johannesburg 8
Montreal 8
Redmond 8
Sterling 8
Sydney 8
University Center 8
Amsterdam 7
Atlanta 7
Boston 7
Brno 7
Brooklyn 7
Falls Church 7
Hefei 7
Mountain View 7
Ribeirão Preto 7
Saint Petersburg 7
Shanghai 7
Tampa 7
Zhengzhou 7
Bologna 6
Frankfurt am Main 6
Hải Dương 6
Miami 6
Mumbai 6
Nanjing 6
New Delhi 6
Orem 6
Poplar 6
Recife 6
Turin 6
Verona 6
Baghdad 5
Belo Horizonte 5
Brasília 5
Columbus 5
Erbil 5
Haiphong 5
Totale 19.885
Salva come PNG Salva come JPEG
Nome #
Current role of perampanel in pediatric epilepsy 505
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 460
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 450
Cognitive development in females with PCDH19 gene-related epilepsy 443
mTOR Inhibitors in Tuberous Sclerosis Complex. 439
Peri-ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy 427
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 420
Current role of melatonin in pediatric neurology: Clinical recommendations 418
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 417
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 413
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 412
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 407
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 404
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 402
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 397
Long-term follow-up in children with benign convulsions associated with gastroenteritis 396
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 390
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 389
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 384
Syndromic autism: Causes and pathogenetic pathways 383
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 383
The neurobiology of attention deficit/hyperactivity disorder. 382
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 377
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 377
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 377
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. 372
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 370
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 370
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 369
Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas 369
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis. 366
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study 365
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. 364
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective 361
The neurobiological basis of ADHD. 359
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. 359
Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia 359
MTOR inhibitors as a new therapeutic option for epilepsy 354
Attention deficit hyperactivity disorder in children with epilepsy. 351
Paediatric use of melatonin (Author reply to D. J. Kennaway). 350
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 343
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. 341
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. 340
Can we change the course of epilepsy in tuberous sclerosis complex? 330
Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State 320
New perspectives in Autism spectrum disorder associated with tuberous sclerosis 305
Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. 292
Pharmacotherapy of idiopathic generalized epilepsies 284
Neuroimaging findings of Sturge-Weber Syndrome in a child with Tuberous Sclerosis 281
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations 273
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 272
Recent advances in neurobiology of Tuberous Sclerosis Complex 262
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) 226
Autism spectrum disorder and 3p24.3p23 triplication: a case report 197
mTOR dysregulation and tuberous sclerosis-related epilepsy 171
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: A Delphi consensus report 166
Everolimus for Retinal Astrocytic Hamartomas in Tuberous Sclerosis Complex 163
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study 150
Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study 144
Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria 140
Prophylactic treatment of pediatric migraine: Is there anything new in the last decade? 136
Immediate and prolonged-release melatonin in children with neurodevelopmental disabilities. Author reply to Prof. Zisapel 131
Features of primary chronic headache in children and adolescents and validity of ICHD 3 criteria 130
Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study 109
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex? 102
Restless legs syndrome and growing pains in childhood: understanding the link 86
Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report 82
Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine 79
Case Report: Migralepsy: The Two-Faced Janus of Neurology 77
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial 75
Autism and epilepsy in patients with Tuberous Sclerosis Complex 74
Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination 70
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review 70
Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study 69
Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study 63
Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes 63
Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex 62
Sleep disturbances and behavioral symptoms in pediatric Sotos syndrome 61
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children 61
Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic 59
Restless sleep disorder in a sample of children and adolescents with autism spectrum disorder: preliminary results from a case series 58
Sleep-related painful erection: the first case in a child 58
Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience 58
A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome 57
Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge 55
High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample 52
Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review 51
Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents - A questionnaire-based study 51
Primary Headaches and Sleep Disorders: Review of Literature about Comorbidity in Children and Adolescents 51
Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity? 51
Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit 49
How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents 46
miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex 44
Prenatal mTOR Inhibitors in Tuberous Sclerosis Complex: Current Insights and Future Directions 43
Toward targeted treatments in tuberous sclerosis 42
Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review 42
Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study 42
Long-term use of {mTORC}1 inhibitors in tuberous sclerosis complex associated neurological aspects 41
Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns 41
Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what 41
Totale 23.322
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.381 0 0 0 0 0 387 392 272 68 87 142 33
2021/2022729 33 53 28 9 18 62 25 21 159 54 52 215
2022/2023848 96 89 17 81 79 232 87 35 67 3 39 23
2023/2024407 42 9 21 3 28 97 8 3 2 12 96 86
2024/20252.821 57 662 353 153 80 178 140 101 140 452 254 251
2025/20261.849 298 193 482 270 496 110 0 0 0 0 0 0
Totale 23.802